Crossmark

In reply to: Confirmation of antibodies against hepatitis C virus by recombinant immunoblot: Is it really an improvement to abandon it?

Crossref DOI link: https://doi.org/10.1016/j.eimce.2019.07.002

Published Print: 2020-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García, Federico

Aguilera, Antonio

Crespo, Javier

Pineda, Juan A.
License Information

Text and Data Mining valid from 2020-02-01
More Information

This article is maintained by: Elsevier

Article Title: In reply to: Confirmation of antibodies against hepatitis C virus by recombinant immunoblot: Is it really an improvement to abandon it?

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2019.07.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2019.05.008

Content Type: simple-article

Copyright: © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.